M A B van der Sande

Summary

Affiliation: Medical Research Council Laboratories
Country: The Gambia

Publications

  1. ncbi Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communities
    M A van der Sande
    Medical Research Council Laboratories, Fajara, The Gambia
    J Hum Hypertens 14:489-96. 2000
  2. ncbi Cardiovascular disease in sub-Saharan Africa: a disaster waiting to happen
    M A B van der Sande
    MRC Laboratories, PO Box 274, Banjul, The Gambia
    Neth J Med 61:32-6. 2003
  3. ncbi Body mass index at time of HIV diagnosis: a strong and independent predictor of survival
    Marianne A B van der Sande
    Medical Research Council Laboratories, Fajara, Banjul, The Gambia
    J Acquir Immune Defic Syndr 37:1288-94. 2004
  4. ncbi A template for improved prevention and control of cardiovascular disease in sub-Saharan Africa
    M A van der Sande
    Medical Research Council Laboratories, Fajara, The Gambia
    Health Policy Plan 16:345-50. 2001
  5. ncbi Geographical variation in prevalence of hypertension within The Gambia
    M A van der Sande
    Medical Research Council Laboratories, Fajara, The Gambia
    J Hum Hypertens 15:733-9. 2001
  6. ncbi Obesity and undernutrition and cardiovascular risk factors in rural and urban Gambian communities
    M A van der Sande
    Medical Research Council Laboratories, PO Box 273, Banjul, The Gambia, Africa
    Am J Public Health 91:1641-4. 2001
  7. ncbi Family history: an opportunity for early interventions and improved control of hypertension, obesity and diabetes
    M A van der Sande
    Medical Research Council Laboratories, Fajara, PO Box 273, Banjul, The Gambia
    Bull World Health Organ 79:321-8. 2001
  8. ncbi Changing causes of death in the West African town of Banjul, 1942-97
    M A van der Sande
    Medical Research Council MRC Laboratories, Fajara, PO Box 273, Banjul, The Gambia
    Bull World Health Organ 79:133-41. 2001
  9. ncbi Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2
    Marianne A B van der Sande
    London School of Hygiene and Tropical Medicine, London, UK
    AIDS 18:1933-41. 2004
  10. ncbi Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life
    M A B van der Sande
    Medical Research Council Laboratories, Fajara, The Gambia
    Vaccine 25:1509-12. 2007

Detail Information

Publications16

  1. ncbi Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communities
    M A van der Sande
    Medical Research Council Laboratories, Fajara, The Gambia
    J Hum Hypertens 14:489-96. 2000
    ..In view of limited resources and feasibility of intervention in rural Gambia, these could initially be directed towards urbanised populations...
  2. ncbi Cardiovascular disease in sub-Saharan Africa: a disaster waiting to happen
    M A B van der Sande
    MRC Laboratories, PO Box 274, Banjul, The Gambia
    Neth J Med 61:32-6. 2003
    ..This short review deals with the strong increase in a number of risk factors for CVD in certain areas, necessitating preventive measures to lighten the 'double burden of disease' in this part of the world...
  3. ncbi Body mass index at time of HIV diagnosis: a strong and independent predictor of survival
    Marianne A B van der Sande
    Medical Research Council Laboratories, Fajara, Banjul, The Gambia
    J Acquir Immune Defic Syndr 37:1288-94. 2004
    ..Identification of basic prognostic indicators of HIV infection is essential before widespread antiretroviral therapy can be implemented in low-technology settings. This study assessed how well body mass index (BMI:kg/m2) predicts survival...
  4. ncbi A template for improved prevention and control of cardiovascular disease in sub-Saharan Africa
    M A van der Sande
    Medical Research Council Laboratories, Fajara, The Gambia
    Health Policy Plan 16:345-50. 2001
    ..Recommended strategies include decentralizing the design and implementation of programmes, with appropriate standardized surveillance of major risk factors, all complemented by operational, epidemiological and basic research...
  5. ncbi Geographical variation in prevalence of hypertension within The Gambia
    M A van der Sande
    Medical Research Council Laboratories, Fajara, The Gambia
    J Hum Hypertens 15:733-9. 2001
    ..3-2.2). The observed coefficient of variation in hypertension prevalence, k, was 0.30. Thus we confirmed significant geographical variation in prevalence of hypertension over time, which has implications for planning of interventions...
  6. ncbi Obesity and undernutrition and cardiovascular risk factors in rural and urban Gambian communities
    M A van der Sande
    Medical Research Council Laboratories, PO Box 273, Banjul, The Gambia, Africa
    Am J Public Health 91:1641-4. 2001
    ..This study documented the prevalence of and cardiovascular risk factors associated with obesity and undernutrition in the Gambia...
  7. ncbi Family history: an opportunity for early interventions and improved control of hypertension, obesity and diabetes
    M A van der Sande
    Medical Research Council Laboratories, Fajara, PO Box 273, Banjul, The Gambia
    Bull World Health Organ 79:321-8. 2001
    ....
  8. ncbi Changing causes of death in the West African town of Banjul, 1942-97
    M A van der Sande
    Medical Research Council MRC Laboratories, Fajara, PO Box 273, Banjul, The Gambia
    Bull World Health Organ 79:133-41. 2001
    ..Most mortality analyses for sub-Saharan Africa have involved extrapolation and have not been derived from community-based data...
  9. ncbi Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2
    Marianne A B van der Sande
    London School of Hygiene and Tropical Medicine, London, UK
    AIDS 18:1933-41. 2004
    ..HIV-2 has been associated with less immune suppression, slower disease progression and longer survival...
  10. ncbi Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life
    M A B van der Sande
    Medical Research Council Laboratories, Fajara, The Gambia
    Vaccine 25:1509-12. 2007
    ..To confirm this comparable vaccine efficacy a randomised controlled non-inferiority trial with long-term follow-up is needed...
  11. ncbi Absence of association between delayed type hypersensitivity to tuberculin and atopy in children in The Gambia
    M O C Ota
    Medical Research Council Laboratories, The Gambia
    Clin Exp Allergy 33:731-6. 2003
    ..An inverse association between delayed type hypersensitivity to tuberculin and atopy has been observed in children, suggesting that exposure to mycobacteria may influence the immune response to allergens...
  12. ncbi Severe respiratory syncytial virus infection in early life is associated with increased type 2 cytokine production in Gambian children
    M A B van der Sande
    Medical Research Council Laboratories, Fajara, The Gambia
    Clin Exp Allergy 32:1430-5. 2002
    ..The aim of this study was to test if severe RSV infection in early life was associated with an increase in type 2 cytokine production and atopy in Gambian children 5 years later...
  13. ncbi Long-term protection against carriage of hepatitis B virus after infant vaccination
    M A B van der Sande
    Medical Research Council, Fajara, The Gambia
    J Infect Dis 193:1528-35. 2006
    ..Infant vaccination has been effective in preventing horizontal transmission during early childhood. It is unknown whether protection is maintained into early adulthood...
  14. ncbi Dual HIV-1 and HIV-2 infection in a West African infant
    M A B van der Sande
    Ann Trop Paediatr 24:277-8. 2004
  15. ncbi An ongoing outbreak of lymphogranuloma venereum in the Netherlands, 2006-2007
    F D H Koedijk
    Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
    Euro Surveill 12:E070419.2. 2007
  16. ncbi Sudden deaths following influenza vaccination: can this be expected?
    M A B van der Sande
    Epidemiology and Surveillance Unit, Centre Infectious Disease Control, National Institute of Public Health and the Environment RIVM, Bilthoven, The Netherlands
    Vaccine 26:379-82. 2008
    ..In November 2006, four Dutch people, aged 53, 58, 80 and 88, died unexpectedly on the day they had received their influenza vaccination. A rapid epidemiological assessment was needed to quantify the risk of a causal association...